Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 3 |
2023 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Osteoblast/osteocyte-derived interleukin-11 regulates osteogenesis and systemic adipogenesis.
Nat Commun. 2022 Nov 23;13(1):7194. doi: 10.1038/s41467-022-34869-3.
Nat Commun. 2022.
PMID: 36424386
Free PMC article.
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors.
Nakaue E, Teramachi J, Tenshin H, Hiasa M, Harada T, Oda A, Inoue Y, Shimizu S, Higa Y, Sogabe K, Oura M, Hara T, Sumitani R, Maruhashi T, Yamagami H, Endo I, Tanaka E, Abe M.
Nakaue E, et al. Among authors: higa y.
Int J Hematol. 2023 Jul;118(1):88-98. doi: 10.1007/s12185-023-03601-2. Epub 2023 Apr 11.
Int J Hematol. 2023.
PMID: 37039914
Free PMC article.
Item in Clipboard
Mechanical unloading aggravates bone destruction and tumor expansion in myeloma.
Tanimoto K, Hiasa M, Tenshin H, Teramachi J, Oda A, Harada T, Higa Y, Sogabe K, Oura M, Sumitani R, Hara T, Endo I, Matsumoto T, Tanaka E, Abe M.
Tanimoto K, et al. Among authors: higa y.
Haematologica. 2022 Mar 1;107(3):744-749. doi: 10.3324/haematol.2021.278295.
Haematologica. 2022.
PMID: 34788982
Free PMC article.
No abstract available.
Item in Clipboard
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2.
Higa Y, Hiasa M, Tenshin H, Nakaue E, Tanaka M, Kim S, Nakagawa M, Shimizu S, Tanimoto K, Teramachi J, Harada T, Oda A, Oura M, Sogabe K, Hara T, Sumitani R, Maruhashi T, Yamagami H, Endo I, Matsumoto T, Tanaka E, Abe M.
Higa Y, et al.
Antioxidants (Basel). 2023 Jan 5;12(1):133. doi: 10.3390/antiox12010133.
Antioxidants (Basel). 2023.
PMID: 36670994
Free PMC article.
Item in Clipboard
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.
Ashtar M, Tenshin H, Teramachi J, Bat-Erdene A, Hiasa M, Oda A, Tanimoto K, Shimizu S, Higa Y, Harada T, Oura M, Sogabe K, Nakamura S, Fujii S, Sumitani R, Miki H, Udaka K, Takahashi M, Kagawa K, Endo I, Tanaka E, Matsumoto T, Abe M.
Ashtar M, et al. Among authors: higa y.
Cancers (Basel). 2020 Apr 9;12(4):929. doi: 10.3390/cancers12040929.
Cancers (Basel). 2020.
PMID: 32283857
Free PMC article.
Item in Clipboard
TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expression.
Tenshin H, Teramachi J, Ashtar M, Hiasa M, Inoue Y, Oda A, Tanimoto K, Shimizu S, Higa Y, Harada T, Oura M, Sogabe K, Hara T, Sumitani R, Maruhashi T, Sebe M, Tsutsumi R, Sakaue H, Endo I, Matsumoto T, Tanaka E, Abe M.
Tenshin H, et al. Among authors: higa y.
Clin Transl Immunology. 2022 Jan 19;11(1):e1371. doi: 10.1002/cti2.1371. eCollection 2022.
Clin Transl Immunology. 2022.
PMID: 35079379
Free PMC article.
Item in Clipboard
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
Sogabe K, Nakamura S, Higa Y, Miki H, Oda A, Maruhashi T, Sumitani R, Oura M, Takahashi M, Nakamura M, Maeda Y, Hara T, Yamagami H, Fujii S, Kagawa K, Ozaki S, Kurahashi K, Endo I, Aihara KI, Nakaue E, Hiasa M, Teramachi J, Harada T, Abe M.
Sogabe K, et al. Among authors: higa y.
Int J Hematol. 2024 Mar;119(3):303-315. doi: 10.1007/s12185-023-03705-9. Epub 2024 Jan 21.
Int J Hematol. 2024.
PMID: 38245883
Item in Clipboard
Cite
Cite